270 related articles for article (PubMed ID: 8534270)
1. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
2. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
4. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
[TBL] [Abstract][Full Text] [Related]
5. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
6. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
11. High affinity agonist binding to cloned 5-hydroxytryptamine2 receptors is not sensitive to GTP analogs.
Szele FG; Pritchett DB
Mol Pharmacol; 1993 Jun; 43(6):915-20. PubMed ID: 8316223
[TBL] [Abstract][Full Text] [Related]
12. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
14. Evidence for distinct 5-hydroxytryptamine2 binding site subtypes in cortical membrane preparations.
Pierce PA; Peroutka SJ
J Neurochem; 1989 Feb; 52(2):656-8. PubMed ID: 2911036
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
16. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
Pinto W; Battaglia G
Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
[TBL] [Abstract][Full Text] [Related]
17. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
18. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
20. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]